(Neo:NETZ.NE),(OTC US:OFSTF),(OTCQB:OFSTF),(Boerse Frankfurt – Freiverkehr:M2Q), TORONTO, Jan. 29, 2025 (GLOBE NEWSWIRE) — Carbon Streaming Corporation (Cboe CA: NETZ) (OTCQB: OFSTF) (FSE: M2Q) (“Carbon Streaming” or the “Company“) today provided a project update with respect to the Purchase and Sale Agreement dated as of May 9, 2023, as amended pursuant to that First Amending Agreement, dated […]
(CNSX:VOY.CN),(CNSX:VOY), TORONTO, Jan. 29, 2025 (GLOBE NEWSWIRE) — Voyageur Mineral Explorers Corp. (“Voyageur” or the “Company“) (CSE: VOY) is pleased to announce its intention to commence a normal course issuer bid (the “NCIB“), under which it may purchase up to an aggregate of 1,613,419 common shares of the Company (“Common Shares“), representing approximately 5% of
(TSX-V:MD), MONTREAL, Jan. 29, 2025 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland“) (TSX-V: MD) is pleased to give an overview of its exploration activities planned for 2025 in Quebec, including on its several projects in partnership for gold in the Abitibi belt, lithium in James Bay region, copper-nickel in the Nunavik, and copper-gold in the
(NASDAQ:PMN), CAMBRIDGE, Massachusetts, Jan. 29, 2025 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), today announced that Neil Warma, Chief Executive
(NasdaqGM:ALT), GAITHERSBURG, Md., Jan. 29, 2025 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company's management team will participate in a fireside chat at the Guggenheim SMID Cap Biotech Conference. Details are as follows: Conference: Guggenheim SMID Cap Biotech Conference Date/Time: Wednesday, February 5, 2025, at
(TSX:ARG),(OTC US:ARREF),(Other OTC:ARREF), VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) — Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF) (“Amerigo” or the “Company”) is pleased to announce that Minera Valle Central (“MVC”), the Company's 100% owned operation located near Rancagua, Chile, has reached a significant safety milestone, marked by three consecutive years without lost-time accidents.
BRIDGEWATER, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) — Vyluma, Inc. (“Vyluma”), a biopharmaceutical company advancing novel treatments for refractive errors, announced today that the National Medical Products Administration (NMPA) of China has accepted the drug application from Zhaoke Ophthalmology Limited (“Zhaoke”) for its lead compound, NVK002 (low-dose atropine 0.01%), as a potential treatment for myopia
(NasdaqGM:APGE), SAN FRANCISCO and BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) — Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will participate in a fireside chat at the Guggenheim SMID Cap Biotech Conference on Wednesday, February 5, 2025 at 1:00 p.m. E.T. A live and archived webcast of the fireside chat will be
NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your Marqeta, Inc. (NASDAQ:MQ) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/marqeta-inc-lawsuit-submission-form?prid=125719&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / January 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Neumora Therapeutics, Inc. ("Neumora Therapeutics, Inc.") (NASDAQ:NMRA) concerning possible violations of federal securities laws. On January 2, 2025, Neumora announced its experimental depression treatment failed in the first of three studies planned